0000000000148810

AUTHOR

Annalisa Dalmoro

showing 3 related works from this author

PHEA-PLA biocompatible nanoparticles by technique of solvent evaporation from multiple emulsions

2015

Nanocarriers of amphiphilic polymeric materials represent versatile delivery systems for poorly water soluble drugs. In this work the technique of solvent evaporation from multiple emulsions was applied to produce nanovectors based on new amphiphilic copolymer, the α,β-poly(N-2-hydroxyethyl)-DL-aspartamide-polylactic acid (PHEA-PLA), purposely synthesized to be used in the controlled release of active molecules poorly soluble in water. To this aim an amphiphilic derivative of PHEA, a hydrophilic polymer, was synthesized by derivatization of the polymeric backbone with hydrophobic grafts of polylactic acid (PLA). The achieved copolymer was thus used to produce nanoparticles loaded with α toc…

3003Biocompatible polymerPolymersChemistry PharmaceuticalDrug CompoundingPolyestersalpha-TocopherolPharmaceutical Sciencechemistry.chemical_compoundDrug Delivery SystemsNanoparticlePolylactic acidAmphiphileOrganic chemistryLactic AcidSolubilityDrug CarriersUltrasonic energyPHEA-PLAEmulsionAmphiphilic polymerControlled releaseSolventDrug LiberationSolubilitychemistryChemical engineeringDelayed-Action PreparationsDrug deliveryDrug deliverySolventsNanoparticlesEmulsionsNanocarriersPeptidesDrug carrierHydrophobic and Hydrophilic Interactions
researchProduct

Lipid Delivery Systems for Nucleic-Acid-Based-Drugs: From Production to Clinical Applications

2019

In the last years the rapid development of Nucleic Acid Based Drugs (NABDs) to be used in gene therapy has had a great impact in the medical field, holding enormous promise, becoming “the latest generation medicine” with the first ever siRNA-lipid based formulation approved by the United States Food and Drug Administration (FDA) for human use, and currently on the market under the trade name Onpattro™. The growth of such powerful biologic therapeutics has gone hand in hand with the progress in delivery systems technology, which is absolutely required to improve their safety and effectiveness. Lipid carrier systems, particularly liposomes, have been proven to be the most su…

liposomes0303 health sciencesclinical trialsNABDsComputer sciencelcsh:RS1-441Pharmaceutical Science02 engineering and technologyLimitingReview021001 nanoscience & nanotechnologylcsh:Pharmacy and materia medicaClinical trialFood and drug administration03 medical and health sciencesHuman useRisk analysis (engineering)siRNAProduction (economics)NABDs; SiRNA; Liposomes; Clinical trials0210 nano-technology030304 developmental biologyPharmaceutics
researchProduct

Advances in Nanoliposomes Production for Ferrous Sulfate Delivery

2020

In this study, a continuous bench scale apparatus based on microfluidic fluid dynamic principles was used in the production of ferrous sulfate-nanoliposomes for pharmaceutical/nutraceutical applications, optimizing their formulation with respect to the products already present on the market. After an evaluation of its fluid dynamic nature, the simil-microfluidic (SMF) apparatus was first used to study the effects of the adopted process parameters on vesicles dimensional features by using ultrasonic energy to enhance liposomes homogenization. Subsequently, iron-nanoliposomes were produced at different weight ratios of ferrous sulfate to the total formulation components (0.06, 0.035, 0.02, an…

sonicationMaterials sciencenanoliposomeSonicationMicrofluidicslcsh:RS1-441Pharmaceutical Sciencenanoliposome; drug delivery; ferrous sulfate; simil-microfluidic apparatus; sonication;02 engineering and technology030226 pharmacology & pharmacyHomogenization (chemistry)ArticleFerrouslcsh:Pharmacy and materia medica03 medical and health sciences0302 clinical medicineLiposomeVesiclesimil-microfluidic apparatus021001 nanoscience & nanotechnologyChemical engineeringdrug deliveryDrug deliveryUltrasonic sensor0210 nano-technologyferrous sulfatePharmaceutics
researchProduct